Literature DB >> 10566628

Menstrual cycle effects on urinary estrogen metabolites.

X Xu1, A M Duncan, B E Merz-Demlow, W R Phipps, M S Kurzer.   

Abstract

Endogenous estrogen metabolism may play an important role in the pathogenesis of hormone-related cancers, most notably breast cancer. Despite the importance of estrogen metabolism, little is known about estrogen metabolite profiles during different phases of the menstrual cycle. This study was performed to evaluate the effects of the menstrual cycle on endogenous estrogen metabolism. Twenty-four-hour urine samples were collected daily during 4 precisely defined phases of the menstrual cycle (early follicular, midfollicular, periovulatory, and midluteal phases) from 6 healthy premenopausal women. Urine samples were analyzed for 15 endogenous estrogens and their metabolites by an ion exchange chromatography and the capillary gas chromatography-mass spectrometry method. The patterns of urinary estrogen metabolites (including potentially genotoxic 16alpha-hydroxyestrone, 4-hydroxyestradiol, and 4-hydroxyestrone) followed those of plasma estradiol and estrone, showing significant increases in the periovulatory and midluteal phases. Compared to the early and midfollicular phases, the ratios of 2-hydroxyestrogens/16alpha-hydroxyestrogens and 2-hydroxyestrogens/4-hydroxyestrogens were significantly increased during the periovulatory and midluteal phases (by 28% and 72%, respectively; P < 0.05), suggesting that estrogen metabolism is significantly affected by menstrual cycle phase. These data indicate that menstrual cycle phase must be considered in studies of estrogen metabolism in premenopausal women.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566628     DOI: 10.1210/jcem.84.11.6134

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Association of estrogen measurements in serum and urine of premenopausal women.

Authors:  Gertraud Maskarinec; Fanchon Beckford; Yukiko Morimoto; Adrian A Franke; Frank Z Stanczyk
Journal:  Biomark Med       Date:  2015       Impact factor: 2.851

2.  Soy intake is associated with increased 2-hydroxylation and decreased 16alpha-hydroxylation of estrogens in Asian-American women.

Authors:  Barbara J Fuhrman; Ruth Pfeiffer; Xia Xu; Anna H Wu; Larissa Korde; Mitchell H Gail; Larry K Keefer; Timothy D Veenstra; Robert N Hoover; Regina G Ziegler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-29       Impact factor: 4.254

3.  Stable isotope-coded quaternization for comparative quantification of estrogen metabolites by high-performance liquid chromatography-electrospray ionization mass spectrometry.

Authors:  Wen-Chu Yang; Fred E Regnier; Dan Sliva; Jiri Adamec
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-06-20       Impact factor: 3.205

4.  Green tea intake is associated with urinary estrogen profiles in Japanese-American women.

Authors:  Barbara J Fuhrman; Ruth M Pfeiffer; Anna H Wu; Xia Xu; Larry K Keefer; Timothy D Veenstra; Regina G Ziegler
Journal:  Nutr J       Date:  2013-02-15       Impact factor: 3.271

5.  Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer?

Authors:  Nadia Obi; Alina Vrieling; Judith Heinz; Jenny Chang-Claude
Journal:  Int J Womens Health       Date:  2011-02-08

6.  Reference intervals for the urinary steroid metabolome: The impact of sex, age, day and night time on human adult steroidogenesis.

Authors:  Daniel Ackermann; Michael Groessl; Menno Pruijm; Belen Ponte; Geneviève Escher; Claudia H d'Uscio; Idris Guessous; Georg Ehret; Antoinette Pechère-Bertschi; Pierre-Yves Martin; Michel Burnier; Bernhard Dick; Bruno Vogt; Murielle Bochud; Valentin Rousson; Nasser A Dhayat
Journal:  PLoS One       Date:  2019-03-29       Impact factor: 3.240

7.  Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study.

Authors:  Chi-Chen Hong; Bing-Kou Tang; Geoffrey L Hammond; David Tritchler; Martin Yaffe; Norman F Boyd
Journal:  Breast Cancer Res       Date:  2004-05-07       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.